Anuna AI

• Mission: Anuna AI is an early-stage biotechnology and healthcare technology company building a highly personalized "Health SuperIntelligence" platform. Their overarching strategy is to fundamentally empower patients with absolute health sovereignty and comprehensive data ownership, strategically shifting the paradigm from reactive, legacy-based treatments to proactive, AI-driven personalized health management and precision therapeutics.
• Core Innovation: The core "secret sauce" of Anuna AI lies in their sophisticated integration of advanced artificial intelligence with complex life sciences, specifically targeting high-impact areas like AI drug discovery, immunotherapy, and cell therapy. By computationally engineering immune cells and utilizing vast bioinformatics networks, they directly address the friction of the antiquated healthcare system.
• Impact: Their work focuses on accelerating viable treatments for cancer and autoimmune disorders while returning control of critical health data back to the individual patient, dismantling traditional medical silos.
• Operations: The company is currently operating an exclusive "Alpha" program. The service is delivered by combining proprietary machine learning algorithms, deep data analytics, and computational biology to engineer cells and discover novel pharmacological solutions tailored to individual patient profiles.
• Leadership & Reach: Founded by CEO Caleb McClain, Anuna AI operates out of New York City and Delaware. The founding team merges multidisciplinary backgrounds in biotechnology, applied machine learning, computational chemistry, and systems sciences. The company is currently in its pre-seed funding stage.